1 Goldman-Rakic PS, "Working momory dysfunction in schizophrenia. In: The Frontal Loves and Neuropsychiatric Illness" American Psychiatric Publishing, Inc 71-82, 2001
2 Wechsler D, "Wechsler Memory Scale, third edition" The Psychological Corporation, Harcourt Brace & Company 1997
3 Fukushima J, "Voluntary control of saccadic eye movements in patients with schizophrenic and affective dis-orders" 24 : 9-24, 1990
4 Vincent GM, "The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome" 327 : 846-852, 1992
5 Glahn DC, "The feasibility of neuropsychological endophenotypes in the search for genes associated with bipolar affective disorder" 6 : 171-182, 2004
6 Gottesman II, "The endophenotype concept in psychiatry: etymology and strategic intentions" 160 : 636-645, 2003
7 Braff DL, "The Investigators of the Consortium on the Genetics of Schizophrenia. Advances in endophenotyping schizophrenia" 7 : 11-18, 2008
8 Gur RE, "The Consortium on the Genetics of Schizophrenia: neurocognitive endophenotypes" 33 : 49-68, 2007
9 Calkins ME, "The Consortium on the Genetics of Endophenotypes in Schizophrenia: model recruitment, assessment, and endophenotyping methods for a multisite collaboration" 33 : 33-48, 2007
10 Waldman ID, "Statistical approaches to complex phenotypes: evaluating neuropsychological endophenotypes for attention-deficit/hyperactivity disorder" 57 : 1347-156, 2005
1 Goldman-Rakic PS, "Working momory dysfunction in schizophrenia. In: The Frontal Loves and Neuropsychiatric Illness" American Psychiatric Publishing, Inc 71-82, 2001
2 Wechsler D, "Wechsler Memory Scale, third edition" The Psychological Corporation, Harcourt Brace & Company 1997
3 Fukushima J, "Voluntary control of saccadic eye movements in patients with schizophrenic and affective dis-orders" 24 : 9-24, 1990
4 Vincent GM, "The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome" 327 : 846-852, 1992
5 Glahn DC, "The feasibility of neuropsychological endophenotypes in the search for genes associated with bipolar affective disorder" 6 : 171-182, 2004
6 Gottesman II, "The endophenotype concept in psychiatry: etymology and strategic intentions" 160 : 636-645, 2003
7 Braff DL, "The Investigators of the Consortium on the Genetics of Schizophrenia. Advances in endophenotyping schizophrenia" 7 : 11-18, 2008
8 Gur RE, "The Consortium on the Genetics of Schizophrenia: neurocognitive endophenotypes" 33 : 49-68, 2007
9 Calkins ME, "The Consortium on the Genetics of Endophenotypes in Schizophrenia: model recruitment, assessment, and endophenotyping methods for a multisite collaboration" 33 : 33-48, 2007
10 Waldman ID, "Statistical approaches to complex phenotypes: evaluating neuropsychological endophenotypes for attention-deficit/hyperactivity disorder" 57 : 1347-156, 2005
11 Benes FM, "Searching for unique endophenotypes for schizophrenia and bipolar disorder within neural circuits and their molecular regulatory mechanisms" 33 : 932-936, 2007
12 Gottesman II, "Schizophrenia and genetics: a twin study vantage point" Academic Press 1972
13 Braff D, "Prestimulus effects on human startle reflex in normals and schizophrenics" 15 : 339-343, 1978
14 Graham FK., "Presidential Address, 1974. The more or less startling effects of weak prestimulation" 12 : 238-248, 1975
15 Freedman R, "Orr-Urtreger A, Olincy A, Davis A. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus" 94 : 587-592, 1997
16 Freedman R, "Neurophysiological evidence for a defect in inhibitory pathways in schizophrenia: comparison of medicated and drug-free patients" 18 : 537-551, 1983
17 Turetsky BI, "Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures" 33 : 69-94, 2007
18 Green MF, "Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the “right stuff”?" 26 : 119-136, 2000
19 Kopelowicz A, "Neurocognitive correlates of recovery from schizophrenia" 35 : 1165-1173, 2005
20 Swerdlow NR, "Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges" 156 : 194-215, 2001
21 Cadenhead KS, "Modulation of the startle response and startle laterality in relatives of schizophrenic patients and in subjects with schizotypal personality disorder: evidence of inhibitory deficits" 157 : 1660-1668, 2000
22 Keating M, "Linkage of a cardiac arrhythmia, the long QT syndrome, and the Harvey ras-1 gene" 252 : 704-706, 1991
23 Swerdlow NR, "Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington’s disease" 58 : 192-200, 1995
24 Conblatt BA, "Impaired attention as an endophenotype for molecular genetic studies of schizophrenia" 105 : 11-15, 2001
25 Almasy L, "Endophenotypes as quantitative risk factors for psychiatric disease: rationale and study design" 105 : 42-44, 2001
26 McGhie A, "Disorders of attention and perception in early schizophrenia" 34 : 103-116, 1961
27 Keefe RS, "Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol" 161 : 985-995, 2004
28 Delis D, "California Verbal Learning Test, second edition. Adult Version. Manual" The Psychological Corporation 2000
29 Doyle AE, "Attention-deficit/hyperactivity disorder endophenotypes" 57 : 1324-1335, 2005
30 Swerdlow NR, "A preliminary assessment of sensorimotor gating in patients with obsessive compulsive disorder" 33 : 298-301, 1993